Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
25 Nov 2025
BMI Not Linked to Distal Interphalangeal Joint Osteoarthritis in Rheumatoid Arthritis
Study finds body mass index does not affect incidence or progression of distal interphalangeal joint osteoarthritis in rheumatoid arthritis patients.
23 Nov 2025
Joint Hypermobility Linked to Proprioceptive Deficits but Not Reduced Strength
A new study shows joint hypermobility impairs proprioception but does not reduce strength or functional stability, highlighting the need for targeted neuromuscular training.
21 Nov 2025
Tailored Exercise Programme Reduces Pain and Fatigue in Systemic Sclerosis
New trial shows high-intensity exercise can ease pain and fatigue in systemic sclerosis, improving quality of life and physical function after just 12 weeks.
14 Nov 2025
Biosimilars in Osteoporosis
In this webinar, two experts describe the diagnosis and treatment of osteoporosis, and discuss the potential for biosimilars to broaden…
11 Nov 2025
Epstein–Barr Virus Found to Reprogramme Immune Cells and Trigger Lupus
A new study reveals how Epstein–Barr virus reprogrammes B cells into autoimmune drivers, uncovering a direct mechanism linking EBV infection to lupus development.
9 Nov 2025
New Evidence Supports CAR-T Cells as a Potential Breakthrough in SLE Care
A new systematic review shows CAR T-cell therapy delivers high remission rates, reduced disease activity, and low toxicity in refractory lupus, signalling major treatment potential.
8 Nov 2025
Lupus Alters Brain Structure Even in Symptom-Free Patients, Study Finds
New MRI research shows hidden brain structure and white matter changes in lupus patients without neuropsychiatric symptoms, linked to disease duration and organ damage.
3 Nov 2025
French Study Finds Higher Pregnancy Risks in Women with Systemic Sclerosis
A large French cohort study finds that pregnant women with systemic sclerosis face increased risks of preeclampsia, preterm birth, and postpartum disease progression, underscoring the importance of close multidisciplinary care.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View